Functional analysis of intercellular adhesion molecule‐1‐expressing human thyroid cells
- 1 February 1990
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 20 (2) , 271-275
- https://doi.org/10.1002/eji.1830200207
Abstract
We have tested the potential role of thyroid cell intercellular adhesion molecule‐1 (ICAM‐1) expression by in vitro assays of cell clustering and cytotoxicity. Increased ICAM‐1 appeared within 24 h of thyroid cell stimulation with cytokines and was not inhibited by the antithyroid drug methimazole. Autologous and allogeneic lymphocyte‐thyroid cell cluster formation, assessed by flow cytometry, was reduced by about one‐third in the presence of a monoclonal antibody against ICAM‐1, regardless of whether thyroid cells were expressing basal levels of ICAM‐1 or had been stimulated with interferon‐γ. The cytotoxicity produced by interleukin 2‐stimulated allogeneic lymphocytes was not consistently inhibited by anti‐ICAM‐1 antibody, but phytohemagglutinin‐stimulated lymphocytes showed a reduction of 23% – 28% in cytotoxicity against untreated or interferon‐γ stimulated thyroid cells when the anti‐ICAM‐1 monoclonal antibody was present. Finally, thyroid cells could be infected by rhinovirus, confirming the presence of fully functional ligand. These results show that ICAM‐1 expression by thyroid cells may enhance immune cell recognition and play some role in cytotoxicity, features which could be important in the initiation or perpetuation of autoimmune thyroiditis.This publication has 27 references indexed in Scilit:
- The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognitionImmunology Today, 1989
- Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cellsJournal of Endocrinology, 1989
- The major human rhinovirus receptor is ICAM-1Published by Elsevier ,1989
- A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinovirusesCell, 1989
- Intercellular Adhesion Molecule‐1 (ICAM‐1) Monoclonal Antibody Inhibits Cytotoxic T Lymphocyte RecognitionAnnals of the New York Academy of Sciences, 1988
- Graves' disease: Phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroidClinical Immunology and Immunopathology, 1988
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987
- Effects of monoclonal antibodies to the a and β chains of the human lymphocyte function‐associated (H‐LFA‐1) antigen on T lymphocyte functionsEuropean Journal of Immunology, 1985
- EVIDENCE FOR AN EFFECT OF ANTITHYROID DRUGS ON THE NATURAL HISTORY OF GRAVES' DISEASEClinical Endocrinology, 1984
- Hypothyroidism as a Late Sequela in Patients with Graves' Disease Treated with Antithyroid AgentsJournal of Clinical Investigation, 1979